Muscle wasting is a frequent finding in patients with chronic kidney disease (CKD),
especially in those with end-stage kidney disease (ESKD) on chronic dialysis. Muscle …

Muscle wasting and low muscle mass are prominent features of protein energy wasting
(PEW), sarcopenia and sarcopenic obesity in patients with chronic kidney disease (CKD). In …

Background/objectives Patients with chronic kidney disease (CKD) are subjected to muscle
wasting. Therefore, it is important to investigate surrogate methods that enable the …

BACKGROUND & AIMS: Muscle wasting is considered the best marker of protein-energy
wasting in end-stage renal disease (ESRD). We tested the usefulness of a simple observer …

Progressive and generalized loss of muscle mass (muscle wasting) is a frequent
complication in dialysis patients. Common uremic signs and symptoms such as insulin …

Objectives Patients with chronic kidney disease (CKD) have aberrant changes in body
composition, including low skeletal muscle mass, a feature of “sarcopenia.” The …

Summary Background & aims Protein-Energy Wasting (PEW) is a pathological condition of
renal patients with advanced Chronic Kidney Disease characterized by a progressive …

Aim: A more precise understanding of the aetiology and sequelae of muscle wasting in end‐
stage renal disease (ESRD) is required for the development of effective interventions to …

Background Chronic kidney disease (CKD) is a catabolic condition associated with muscle
wasting and dysfunction, which associates with morbidity and mortality. There is a need for …

Assessment of muscle mass (MM) or its proxies, lean tissue mass (LTM) or fat-free mass
(FFM), is an integral part of the diagnosis of protein-energy wasting (PEW) and sarcopenia …